Showing results (1501-1510 of 1,667) with videos related to

Sort By:
Pageof 167
Molecular Genetics and Metabolism|February 13, 2022
β-Ureidopropionase deficiency due to novel and rare UPB1 mutations affecting pre-mRNA splicing and protein structural integrity and catalytic activityDoreen Dobritzsch, Judith Meijer, Rutger Meinsma, et al.
BMJ Neurology Open|June 25, 2026
AI-driven European Retrospective Database Study to predict disease onset in patients with epilepsy and depressionAlessandro Ruggieri, John Paul Leach, Elena Alvarez-Baron, et al.
Clinical Pharmacokinetics|May 10, 2023
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate CancerS E H Detert Oude Weme, L M G Hulskotte, W L Vervenne, et al.
Cancer Medicine|January 26, 2016
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancerBenoist Chibaudel, Frédérique Maindrault-Gœbel, Jean-Baptiste Bachet, et al.
Journal of Inherited Metabolic Disease|February 13, 2026
Cluster of Severe Arginase 1 Deficiency in the Comoros: Clinical, Neuroimaging, and Molecular Features in 17 Patients From Mayotte Compared With 10 From ParisAurélie de Bruyne, Apolline Imbard, Charles-Joris Roux, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2023
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European CohortJulien Taïeb, Lina Sayah, Kathrin Heinrich, et al.
Molecular Genetics and Metabolism|August 20, 2025
Clinical, biochemical, and molecular findings in adults with hyperammonemia: A French bi-centric retrospective studyJulien Maquet, Clément Pontoizeau, Apolline Imbard, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|April 18, 2018
Pyridoxine dependent epilepsy: Is late onset a predictor for favorable outcome?R L P de Rooy, F J Halbertsma, E A Struijs, et al.
Cancer Medicine|February 17, 2015
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 studyBenoist Chibaudel, Roger Lacave, Marine Lefevre, et al.
Surgery|October 4, 2025
Delayed coloanal anastomosis for rectovaginal fistulas: Insights from a multicenter cohort (GRECCAR)Maxime K Collard, Jean-Jacques Tuech, Benjamin Fernandez, et al.
Pageof 167